HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prevalence of HTLV type I infection in Iran: a serological and genetic study.

Abstract
Several publications describe the presence of the human T cell lymphotropic virus type I (HTLV-I) in Jewish individuals born in Mash-had, Iran. We report here the results of HTLV-I serological and genetic studies in the non-Jewish population of Mash-had as well as a neighboring area: Gonbad-Kavous. Seven hundred and seven serum samples from Mash-had (694 healthy individuals and 13 patients with lymphoma) and 90 from Gonbad-Kavous were tested for HTLV antibodies by gelatin particle agglutination assay (PA) and confirmatory Western blots (WBs). Seropositive rates of 3.0% (21 of 694) in Mash-had, 0% (0 of 90) in Gonbad-Kavous, and 100% (13 of 13) in lymphoma cases were observed. HTLV-I DNA sequence were amplified by polymerase chain reaction directly from the fresh PBMCs of seropositive individuals. Phylogenetic analysis of the viral DNA sequence indicated that the HTLV-I present in Mash-had belong to the HTLV-I cosmopolitan clade. Altogether, these data indicate that Mash-had, located in northeastern Iran, is a newly recognized endemic center for HTLV-I.
AuthorsB Safai, J L Huang, E Boeri, R Farid, J Raafat, P Schutzer, R Ahkami, G Franchini
JournalAIDS research and human retroviruses (AIDS Res Hum Retroviruses) Vol. 12 Issue 12 Pg. 1185-90 (Aug 10 1996) ISSN: 0889-2229 [Print] United States
PMID8844023 (Publication Type: Journal Article)
Topics
  • Amino Acid Sequence
  • Base Sequence
  • HTLV-I Infections (blood, epidemiology, ethnology, genetics)
  • Human T-lymphotropic virus 1 (genetics, isolation & purification)
  • Humans
  • Iran
  • Jews
  • Molecular Sequence Data
  • Serologic Tests

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: